Premier Alternatives

Transcarent

Denver, CO · Founded 2020 · Privately Held (backing)

Developer of a consumer-directed health and care platform designed to facilitate improved outcomes and cost-effective decisions. Transcarent is based in Denver, CO and was founded in 2020. It was valued at $2.7 billion at its later-stage round in Apr 2025, the last priced event on record. It has raised $905 million across 1 recorded round; the latest was a $481 million later-stage round in Apr 2025.

PMV mark · valuation
$2.7B
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$905.0M
Last round
Later Stage VC
Apr 2025

Transcarent key facts

as of Oct 2026
  • Developer of a consumer-directed health and care platform designed to facilitate improved outcomes and cost-effective decisions.
  • Transcarent is valued at approximately $2.7B as of Oct 2026, set at its later-stage round, Apr 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $905.0M across 1 recorded rounds; the latest was Later Stage VC ($481.0M) in Apr 2025.
  • Notable investors include General Catalyst, Kleiner Perkins, Human Capital, Bridgespan VC, Geodesic Capital — 23 tracked in total.
  • Transcarent has filed 1 Form D with the SEC, most recently Apr 2025 ($481.0M sold to 33 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$2.7B

Valued at $2.7B at its later-stage round, Apr 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Transcarent with a free account
  • ·The complete investor list: 23 names
  • ·Watch Transcarent: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Transcarent funding rounds

1 rounds
Apr 2025Later Stage VC$481.0MSEC filing▮
Full funding history →

Transcarent valuation

Transcarent was valued at $2.7 billion at its later-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Transcarent raised?

Transcarent has raised $905 million in total; 1 of its rounds is on record. The largest on record was a $481 million later-stage round in Apr 2025.

Transcarent has filed 1 Form D with the SEC, most recently in Apr 2025 ($481 million sold to 33 investors).

Transcarent investors

23 investors are on record for Transcarent, including General Catalyst, Kleiner Perkins, Human Capital and Bridgespan VC. By type, the record holds 5 venture capital firms and 2 growth equity firms. The later-stage round in Apr 2025 drew 33 investors.

About Transcarent

Developer of a consumer-directed health and care platform designed to facilitate improved outcomes and cost-effective decisions. The company leverages a combination of software, technology stack, and data science to empower consumers with information by directly connecting them with an integrated ecosystem of high-value providers and health services, enabling customers to exercise choice and transparency for addressing a broad range of challenges faced in the modern healthcare system.

Sector
Healthcare
HQ
Denver, CO, United States
Founded
2020
Employees
454
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.